Novo Nordisk (NVO) announced a new $2.2 billion deal with San Francisco-based biotech Sapterna (SEPN) for obesity pills.

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical ...

A new analysis being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May), finds that around half of the 100 top ...

People who take Wegovy appear to be at greater risk for hair loss, according to an early study that hasn't yet been ...

Orlistat (sold as Alli) is one effective over-the-counter weight loss aid that is also FDA-approved.

If a higher body weight is affecting your ability to get around, or you have joint pain from arthritis, it can impair your ...